[ Price : $8.95]
FDA approves Humacytes Symvess for use with some extremity arterial injuries.[ Price : $8.95]
FDA issues a complete response letter for Zealands glepaglutide intended to treat short bowel syndrome.[ Price : $8.95]
FDA warns a Viatris Mylan drug manufacturing facility in Pradesh, India, about CGMP violations involving quality and data issues.[ Price : $8.95]
FDA adds a liver injury Boxed Warning to labeling for Astellas menopause hot flash drug Veozah.[ Price : $8.95]
Lexicon stops development of its diabetes drug Zynquista that received an FDA complete response letter.[ Price : $8.95]
FDA says a Hologic 3/2024 recall correction of BioZorb Markers was Class 1.[ Price : $8.95]
UCB says it is ending the development of minzasolmin, a drug it was working on with Novartis to treat early Parkinsons disease, af...[ Price : $8.95]
FDA issues an alert against the use of certain Baxter Solution Sets with Duo-Vent Spikes because they were incorrectly assembled w...